(Q40468610)

English

West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II co

scientific article published on February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II co (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

West Nile virus

0 references

transmembrane protein

0 references

membrane protein

1 reference

based on heuristic

inferred from title

Genetic vaccine

0 references

Ernesto T A Marques

4

object named as

Ernesto Marques

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Azlinda Anwar

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ananth Chandrasekaran

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Mah Lee Ng

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

J Thomas August

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

332

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

66-77

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Evaluation of vero cell lysate antigen for the ELISA of flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Yellow fever vector live-virus vaccines: West Nile virus vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Electroporation improves the efficacy of DNA vaccines in large animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Current status of flavivirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Molecular bases for the recognition of tyrosine-based sorting signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Signals for sorting of transmembrane proteins to endosomes and lysosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Accessory molecules for MHC class II peptide loading

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Identification of two lysosomal membrane glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Trafficking mechanism of West Nile (Sarafend) virus structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Technical and regulatory hurdles for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

High-efficiency gene electrotransfer into skeletal muscle: description and physiological applicability of a new pulse generator

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

The role of endosomes and lysosomes in MHC class II functioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guérin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Trafficking of MHC class II molecules in the late secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

West Nile virus investigations in South Moravia, Czechland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

A syringe electrode device for simultaneous injection of DNA and electrotransfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Dendritic cells: specialized and regulated antigen processing machines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

CIIV, MIIC and other compartments for MHC class II loading

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Flavivirus West Nile (Sarafend) egress at the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

An overview of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

West Nile virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Traditional and novel approaches to flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA vaccines for flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Migratory birds and West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Antigenic structure of flavivirus proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

CD8 and B cell memory: same strategy, same signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Simultaneous extraction of total RNA and peptides from tissues: application to tachykinins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Transport of peptide-MHC class II complexes in developing dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

HLA-DM - an endosomal and lysosomal chaperone for the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Quality control of MHC class II associated peptides by HLA-DM/H2-M.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

DNA vaccination against persistent viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2004.11.022

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40468610&oldid=1771981507"